PostEra is a biotechnology company using machine learning for medicinal chemistry services that is headquartered in Santa Clara, California and was founded in 2019 by Aaron Morris, Alpha Lee, and Matt Robinson. The company's machine learning algorithms can help design and optimize chemical compounds by exploring new chemical possibilities and optimizing existing scaffolds. PostEra Claims their software tools were the first to beat humans at chemical reaction prediction. Customers of PostEra are able to use their platform to order new chemical compounds.
PostEra has published scientific studies in collaboration with Pfizer to predict bioactivity with low-data limits to improve the performance of prospective experiments by two fold. Another collaborative study with Pfizer showed that PostEra's prediction algorithms are generalizable to the pharmaceutical chemical industry and can predict synthetic pathways to create drug-like molecules.
On March 16, 2020 PostEra announced raising $150,000 in pre-seed funding from Y Combinator.
On March 30, 2020 PostEra announced raising $2.3 million in seed funding from undisclosed investors.